GS1 Standard Would Speed The Sale Of Returned Drugs After November Deadline
New messaging standard from GS1 would enable industry to sell most returned drugs after November DSCSA deadline without running afoul of the FDA.
You may also be interested in...
As expected, the FDA will not take enforcement action against wholesalers that are unable to comply with DSCSA’s saleable return verification requirements by the 27 November deadline.
Pharmaceutical Manufacturers Testing Use of Verification Router Services To Process Saleable Returns Under DSCSA
Pharmaceutical manufacturers, distributors and wholesalers are piloting the use of verification router service (VRS) systems to comply with a looming deadline under DSCSA requiring them to establish systems for verifying saleable returns. Yet there are still many unanswered questions on how these systems will work.
The US FDA has added hydroxychloroquine sulfate to the list of drugs outsourcing facilities can compound as pharmacy group calls for more such approvals with COVID-19 driving demand for additional prescription and over-the-counter drugs.